title: The effect of methyl lidocaine on lysophospholipid metabolism in hamster heart.
abstract: An important feature in the remodelling of fatty acyl chains in cellular phospholipids is the acylation of lysophospholipids. Since lysophospholipids are cytolytic at high concentrations, the acylation reaction may provide an alternate pathway for the removal of cellular lysophospholipids. However, the physiological role of the acylation process in the maintenance of lysophospholipid levels in mammalian tissues has not been clearly defined. In this study, methyl lidocaine was found to inhibit both lysophosphatidylcholine:acyl-CoA and lysophosphatidylethanolamine:acyl-CoA acyltransferase activities in the hamster heart, but the drug had no effect on the other lysophospholipid metabolic enzymes. When the heart was perfused with 0.5 mg methyl lidocaine/mL, acyltransferase activities were attenuated, but there was no change in the activities of phospholipase A or lysophospholipase. The levels of the major lysophospholipids in the heart were not altered by methyl lidocaine perfusion. When the hearts were perfused with labelled lysophospholipid in the presence of methyl lidocaine, there was a reduction in the formation of the phospholipid and an increase in the release of the free fatty acid. However, the labelling of lysophospholipid in the heart was not altered by methyl lidocaine. We postulate that the acylation reaction has no direct contribution to the maintenance of the lysophospholipid levels in the heart.
authors.affiliation: Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
authors.forename: P G
authors.initials: PG
authors.lastname: Tardi
authors.forename: R Y
authors.initials: RY
authors.lastname: Man
authors.forename: C R
authors.initials: CR
authors.lastname: McMaster
authors.forename: P C
authors.initials: PC
authors.lastname: Choy
mesh_terms: D000215:Acylation; D000818:Animals; D006224:Cricetinae; D006321:Heart / Q000187:drug effects*; D008012:Lidocaine / Q000031:analogs & derivatives* / Q000494:pharmacology; D008246:Lysophospholipids / Q000378:metabolism*; D008647:Mesocricetus; D009206:Myocardium / Q000378:metabolism*
chemical_list: D008246:Lysophospholipids; C014672:N-methyllidocaine; D008012:Lidocaine